Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.

Apply

Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.

Journal Title: Singapore Medical Journal - Year 2011, Vol 52, Issue 2

Abstract

An increasing number of patients with chronic hepatitis B infection are being treated with the newly licensed drug, adefovir. It is an acyclic nucleoside phosphonate that is relatively safe in the dosage generally used for chronic hepatitis B. Serious adverse cutaneous drug reactions like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) following adefovir use have not been reported. We report a case of adefovir-induced SJS and TEN overlap syndrome in a patient with chronic hepatitis B infection.

Authors and Affiliations

P Chattopadhyay, N Sarma

Keywords

Adefovir Adverse drug reaction Stevens-Johnson Syndrome toxic epidermal necrolysis

Validity and reliability of the Thai version of the Experiences of Close Relationships-Revised questionnaire.

Introduction: This study aimed to investigate the psychometric properties of the Thai version of the Experiences of Close Relationships-Revised (Thai ECR-R) questionnaire. Methods: 400 students from a university in north...

A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.

Introduction: This study was conducted to compare the genotype and markers of disease severity of chronic hepatitis C (CHC), namely viral load, alanine transaminase (ALT) levels and histopathological findings on liver bi...

EP ID EP129541
DOI -
Views 109
Downloads 0